2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1659470565 M.D.
Verify on CMS →

FAZEELA BAQAI, M.D.

Endocrinology, Diabetes & Metabolism Physician in IRVINE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
636
Medicare Part D claims · 52 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$112.02
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: FAZEELA BAQAI, M.D. is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in IRVINE, California with a Medicare Part D prescribing footprint of 636 claims across 52 beneficiaries — 33% brand-name prescribing . Industry payments of $112.02 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: FAZEELA BAQAI, M.D. filed 636 Medicare Part D claims in 2023 across IRVINE, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

FAZEELA BAQAI, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

FAZEELA BAQAI, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 09/21/2006

NPI 1659470565

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

636 76% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers

Endocrinology, Diabetes & Metabolism Physician share within California

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FAZEELA BAQAI, M.D. is a Endocrinology, Diabetes & Metabolism Physician provider practicing in IRVINE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1659470565. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

FAZEELA BAQAI, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 1 LEAGUE UNIT 61303, IRVINE, CA, 92602, with a listed phone of (949) 427-6989. NPI 1659470565 was issued on 09/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAQAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 636 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $143K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1 LEAGUE UNIT 61303
IRVINE, CA 92602

Provider Details

NPI 1659470565
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 09/21/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FAZEELA BAQAI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$112

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to FAZEELA BAQAI, M.D.. To verify FAZEELA BAQAI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

FAZEELA BAQAI, M.D. — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 636 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

636
Total Claims
$143K
Total Drug Cost
52
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,490
Total Day Supply
44,450
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$128K
Generic Drug Cost
$14K

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
1.44
Gender Split
79% female / 21% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Synthroid
Levothyroxine Sodium
87
Metformin Hcl Er
Metformin Hcl
65
Pravastatin Sodium
56
Liothyronine Sodium
47
Rosuvastatin Calcium
46
Losartan Potassium
40
Trulicity
Dulaglutide
37
Allopurinol
31
Valsartan
26
Levoxyl
Levothyroxine Sodium
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How FAZEELA BAQAI, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

FAZEELA BAQAI, M.D.'s 636 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BAQAI.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is FAZEELA BAQAI, M.D.'s specialty?
FAZEELA BAQAI, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in IRVINE, California. Credentials: M.D..
How much does FAZEELA BAQAI, M.D. prescribe under Medicare Part D?
In 2023, FAZEELA BAQAI, M.D. wrote 636 Medicare Part D claims totaling $143K in drug costs for 52 beneficiaries.
Where is FAZEELA BAQAI, M.D. located?
FAZEELA BAQAI, M.D. is located at 1 LEAGUE UNIT 61303, IRVINE, CA, 92602. Phone: (949) 427-6989.
What is FAZEELA BAQAI, M.D.'s NPI number?
FAZEELA BAQAI, M.D.'s National Provider Identifier (NPI) is 1659470565, issued on 09/21/2006.
Does FAZEELA BAQAI, M.D. prescribe more brand-name or generic drugs?
FAZEELA BAQAI, M.D.'s prescribing is 33% brand-name and 67% generic drugs by claim count, with $128K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does FAZEELA BAQAI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, FAZEELA BAQAI, M.D.'s most frequently prescribed drugs include Synthroid, Metformin Hcl Er, Pravastatin Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FAZEELA BAQAI, M.D. accept Medicare?
FAZEELA BAQAI, M.D. appears in CMS Medicare data with 636 Part D claims and 52 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FAZEELA BAQAI, M.D.'s credentials?
FAZEELA BAQAI, M.D.'s NPI is 1659470565 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology